Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sud-Ouest Capital Risque Innovation (SOCRI) is a French venture capital firm and a subsidiary of the Crédit Agricole regional banks in the South-West of France. The firm specializes in providing equity and quasi-equity financing to small and medium-sized enterprises (SMEs) and innovative startups, particularly those within the life sciences, biotechnology, and healthcare sectors. SOCRI supports regional economic development by investing in companies at various stages, including seed, venture, and growth capital. Its portfolio includes a diverse range of health-related entities, benefiting from the strong innovation hubs in cities like Bordeaux and Toulouse. As a financial partner, SOCRI offers not only capital but also strategic guidance to help regional entrepreneurs scale their technologies. The firm operates as a key player in the French investment landscape, focusing on long-term value creation within the local ecosystem.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sud-Ouest Capital Risque Innovation.